Malaria vaccines: experience with sporozoite vaccines against falciparum malaria. 1988

M M Levine, and D Herrington, and D Clyde, and J Murphy, and J Davis, and R Nussenzweig, and E Nardin, and A Felix, and E Heimer, and D Gillesen
Department of Medicine, University of Maryland School of Medicine, Baltimore 21201.

UI MeSH Term Description Entries
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000953 Antigens, Protozoan Any part or derivative of any protozoan that elicits immunity; malaria (Plasmodium) and trypanosome antigens are presently the most frequently encountered. Protozoan Antigens
D014612 Vaccines Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases. Vaccine

Related Publications

M M Levine, and D Herrington, and D Clyde, and J Murphy, and J Davis, and R Nussenzweig, and E Nardin, and A Felix, and E Heimer, and D Gillesen
December 2015, Vaccine,
M M Levine, and D Herrington, and D Clyde, and J Murphy, and J Davis, and R Nussenzweig, and E Nardin, and A Felix, and E Heimer, and D Gillesen
January 2018, Frontiers in immunology,
M M Levine, and D Herrington, and D Clyde, and J Murphy, and J Davis, and R Nussenzweig, and E Nardin, and A Felix, and E Heimer, and D Gillesen
January 1996, The National medical journal of India,
M M Levine, and D Herrington, and D Clyde, and J Murphy, and J Davis, and R Nussenzweig, and E Nardin, and A Felix, and E Heimer, and D Gillesen
December 1973, The American journal of the medical sciences,
M M Levine, and D Herrington, and D Clyde, and J Murphy, and J Davis, and R Nussenzweig, and E Nardin, and A Felix, and E Heimer, and D Gillesen
July 1947, American journal of hygiene,
M M Levine, and D Herrington, and D Clyde, and J Murphy, and J Davis, and R Nussenzweig, and E Nardin, and A Felix, and E Heimer, and D Gillesen
January 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene,
M M Levine, and D Herrington, and D Clyde, and J Murphy, and J Davis, and R Nussenzweig, and E Nardin, and A Felix, and E Heimer, and D Gillesen
January 2017, Expert review of vaccines,
M M Levine, and D Herrington, and D Clyde, and J Murphy, and J Davis, and R Nussenzweig, and E Nardin, and A Felix, and E Heimer, and D Gillesen
January 1998, Advances in experimental medicine and biology,
M M Levine, and D Herrington, and D Clyde, and J Murphy, and J Davis, and R Nussenzweig, and E Nardin, and A Felix, and E Heimer, and D Gillesen
November 2010, Infection and immunity,
M M Levine, and D Herrington, and D Clyde, and J Murphy, and J Davis, and R Nussenzweig, and E Nardin, and A Felix, and E Heimer, and D Gillesen
June 2015, Vaccine,
Copied contents to your clipboard!